Skip to main content

Written question asked by Kevin Barron (Labour) on Monday, 25 February 2019, in the House of Commons. It was due for an answer on Thursday, 28 February 2019 (named day). A holding answer was provided on Thursday, 28 February 2019. A substantive answer was provided by Steve Brine (Conservative) on Thursday, 21 March 2019 on behalf of the Department of Health and Social Care.


UK Antimicrobial Resistance Diagnostics Collaborative

Question

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 14 February 2019 to Question 219373 on UK Antimicrobial Resistance Diagnostics Collaborative, what representations his Department has received from members of that Collaborative; if he will publish the names of its members; and whether a Chair of that Collaborative has been appointed.

Answer

NHS England established the United Kingdom Antimicrobial Resistance (AMR) Diagnostics Collaborative in 2018 to deliver the UK’s diagnostic ambitions for AMR. The Collaborative has played a valuable role in developing the diagnostic elements of the new five-year UK AMR national action plan, published in January this year.

The work of the Collaborative contributes directly to the Government’s commitments on AMR, and the Collaborative’s secretariat communicates with the Department on a regular basis and it has been represented by its secretariat and former chair in the UK AMR Programme’s governance groups.

The Collaborative’s chair remains vacant while NHS England develops detailed plans to support the implementation of the new national plan on AMR. As part of this work, the membership of the Collaborative is under review.

Current membership is drawn from a range of stakeholders across Government and its agencies, the devolved administrations, the health system, veterinary medicine, professional bodies, academia, the research community and industry. Members at or above ‘very senior manager’ (VSM) level and partner agencies involved in the Collaborative are listed in the following table.

Members of the UK Antimicrobial Resistance Diagnostics Collaborative at or above VSM level

Organisation

Mohamed Sadak

Health Education England

Marion Lyons

Welsh Government

Gerry Waldron

Public Health Agency Northern Ireland

Neil Woodford

Public Health England

Partner Agencies

NHS Scotland

NHS England

NHS Sheffield Clinical Commissioning Group

Department of Health and Social Care

NHS Improvement

University of Bristol

Institute of Biomedical Science

Association of Clinical Biochemistry and Laboratory Medicine

UK Standards for Microbiology Investigations

Royal College of Pathology

Royal College of General Practice

National Institute for Health and Care Excellence (NICE) Medical Technology Guidance

Sherwood Forrest NHS Foundation Trust

Royal College of Nursing

University of Surrey

Addenbrookes Hospital NHS Trust

University of Edinburgh

Medical Research Council

British In Vitro Diagnostic Association

NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative

Innovate UK

NICE

Royal Cornwall Hospital

Kingston University

Department for Environment, Food and Rural Affairs

Responsible Use of Medicines in Agriculture Alliance

University of Liverpool

Ulster University

University of Exeter

Westpoint Farm Vets

University of Nottingham

Centre for Ecology and Hydrology

Cardiff University

Guy’s and St Thomas’ Hospital NHS Foundation Trust

Glasgow Caledonian University


Secondary information

Type
Written question
Reference
225396
Session
2017-19
Related items
UK Antimicrobial Resistance Diagnostics Collaborative
Thursday, 14 February 2019
Written questions
House of Commons
Subjects
UK Antimicrobial Resistance Diagnostics Collaborative
Contains statistics
Yes
Link
View this Written question on www.parliament.uk